FBT (FBT) Stock Price & Analysis
FBT (FBT) fell 0.57% to USD 247.39 as of July 25, 2026 at 13:45 UTC, according to Nexqual real-time market data.
FBT last closed at USD 248.82; the session ranged USD 246.74–248.86 on volume of 219,271 shares. Market capitalization is —, with a 52-week range of USD 161.3–258.2 (PCX). Source: Nexqual, July 25, 2026 at 13:45 UTC.
Key Statistics (as of July 25, 2026 at 13:45 UTC)
| Price | USD 247.39 |
|---|---|
| Change | ▼ 0.57% (down) |
| Previous Close | USD 248.82 |
| Open | USD 249.9 |
| Day Range | USD 246.74 – 248.86 |
| 52-Week Range | USD 161.3 – 258.2 |
| Volume | 219,271 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (FBT)
Nexqual's technical model rates FBT "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 13:45 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.7 (neutral) |
| vs SMA50 | Above (USD 232.45) |
| MACD | 3.96 (positive) |
Financial Health Score (FBT)
Nexqual rates FBT's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 13:45 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FXH | First Trust Health Care AlphaDE | USD 124.05 | ▲ 1.97% |
| PBE | Invesco Biotechnology & Genome | USD 89.59 | ▲ 0.28% |
| BBH | VanEck Biotech ETF | USD 203.57 | ▲ 1.2% |
| PJP | Invesco Pharmaceuticals ETF | USD 120.37 | ▲ 1.33% |
| FDN | First Trust DJ Internet Index F | USD 259.14 | ▼ 2.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:45 UTC. This page is informational and not investment advice.